Trial Profile
Comparison of The Influence of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function For Patients With ST-Segment Elevation Myocardial Infarction Receiving Emergency Percutaneous Coronary Intervention
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms TIGERCAVE
- 24 Feb 2015 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 Jul 2014 New trial record